Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio [Yahoo! Finance]
Hoth Therapeutics, Inc. (HOTH)
Company Research
Source: Yahoo! Finance
will continue its work with Venable, LLP to develop and protect its intellectual property. Venable is an American Lawyer Global 100 law firm that serves as primary counsel to a worldwide clientele of large and mid-sized organizations and nonprofits and individuals. With more than 900 professionals across the country, the firm strategically advances its clients' objectives in the United States and around the globe. Venable advises clients on a broad range of topics, including the full range of intellectual property disciplines. Venable's nationally recognized intellectual property team consistently delivers high-quality, practical analyses and advice rooted in real-world experience. Venable is dedicated to helping clients protect their intellectual property while providing comprehensive advice on strategy, filing and prosecution, licensing, and related enforcement matters. "We believe this collaboration with Venable will greatly add value and further protect our expanding research
Show less
Read more
Impact Snapshot
Event Time:
HOTH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HOTH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HOTH alerts
High impacting Hoth Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
HOTH
News
- Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024 [Yahoo! Finance]Yahoo! Finance
- Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024PR Newswire
- Hoth Therapeutics, Inc. (NASDAQ: HOTH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.MarketBeat
- Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds [Yahoo! Finance]Yahoo! Finance
- Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross ProceedsPR Newswire
HOTH
Analyst Actions
- 4/5/24 - HC Wainwright
HOTH
Sec Filings
- 4/22/24 - Form 424B3
- 4/22/24 - Form EFFECT
- 4/11/24 - Form S-1
- HOTH's page on the SEC website